ADVERTISEMENT
16th Biennial International Andreas Gruentzig Society Meeting
These proceedings summarize the educational activity of the 16th Biennial Meeting of the International Andreas Gruentzig Society held January 31-February 3, 2022 in Punta Cana, Dominican Republic
Faculty Disclosures Vendor Acknowledgments
2022 IAGS Summary Document
Program Agenda
Session 1: Coronary Session 1—Elective PCI
1.1 PCI for QoL in Stable Ischemic Coronary Artery Disease
1.2 Plaque Modification: When to Apply Ablative vs Disruptive Therapies
1.3 Bifurcation Lesions: Stenting Strategies and Will DCBs Change Them?
Session 2: Structural Session 1—Aortic Valve
2.1 TAVR and PCI: Which Lesions and in Whom?
2.2 TAVR Durability: What is it Now and What Do We Need?
2.3 Stroke Prevention for TAVR: What’s Missing?
Session 3: Endovascular Session 1
3.1 Paclitaxel—Friend or Mortal Foe?
3.2 Aortic Frontiers: Will Branched Arch and Thoraco-abdominal Devices Outperform Surgery?
3.3 Carotid Artery Disease: CEA, CAS, TCAR, or Just Pills?
Session 4: Coronary Session 2—STEMI
4.1 COMPLETE Revascularization Following STEMI: Not Whether, When
4.2 Therapies to Minimize Myocardial Injury With and to Promote Myocardial Recovery Following STEMI
4.3 Interventional Pharmacology: Data-Driven Best Practices
Session 5: Structural Session 2—Mitral and Tricuspid Valve
5.1 Interventional vs Surgical Mitral Repair: Are Valve Centers of Excellence Needed?
5.2 TMVR: Programmatic Challenges and Technology Needed to Match Surgical Outcomes
5.3 Tricuspid Valve Interventions: Repair or Replace?
Session 6: Structural Session 3—Atrial
6.1 LAA Occlusion: Will the Latest Tools and Techniques Help Us Overcome the Barriers?
6.2 PFO Closure: What Goes Around Comes Around?
6.3 Multimodality Fusion Imaging for Structural Interventions
Session 7: Hemodynamics Session 1
7.1 Current Role of Hemodynamic Support in Complex, High-Risk PCI
7.2 Hemodynamic Support for STEMI: Door to Unloading Times and Do We Need Systems of Care?
7.3 Contemporary Management of Intermediate- and High-Risk Pulmonary Embolism
Session 8: Endovascular Session 2
8.1 Effectiveness Assessment in PAD: What are the Leading Treatments?
8.2 Drug Delivery for BTK Interventions: Which Drug and What Platform Will Get the Job Done?
8.3 Deep Venous Arterialization for Critical Limb Ischemia
Session 9: Emerging Therapies Session 1
9.1 Coronary Sinus Reduction for Refractory Ischemia
9.2 Current Status of Renal Denervation to Treat Hypertension
9.3 UHD and 3D Coronary Imaging
Session 10: Coronary Session 3
10.1 Latest Techniques and Devices for CTO Intervention: Will They Expand Indications?
10.2 Management of In-Stent Restenosis: Are DCBs the Answer?
10.3 Left Main Disease: How to Assess and When to Intervene in Patients With Aortic Valve Disease
Session 11: Health Care Delivery and Industry Session
11.1 Impact of COVID-19 on Cardiovascular Disease
11.2 Disaster Preparedness for the Cardiovascular Service Line
